Persian
EnglishFanavar Mobtaker Caspian Pharmaceutical Factory is under construction on a 3100 square meter land with a 3600 square meter building with an investment of 13 million Euros. The manufacturing conditions of our products comply with all environmental regulations of this industry. The design, materials and adaptive flows comply with the highest global quality standards for the production of pharmaceutical products.
The construction project of Fanavar Mobtaker Caspian Pharmaceutical Factory is planned and implemented in 4 different phases
phase 1:
This phase is dedicated to general injection products in the form of ampoules, which includes a production site with very high speed, which was put into operation in 2020.
| Product volume (ml) | Annual production (million units) | product type | production line | phase |
| 1-10 | 72 | Ampoule | General | 1 |
phase 2:
This phase is dedicated to injectable anti-cancer products in the form of liquid and powder vials, which will be put into operation at the end of this year and have the following specifications:
| Product volume (ml) | Annual production (million units) | product type | production line | phase |
| 1-100 | 15 | Liquid and powder | Anti-cancer vial | 2 |
Phase 3:
This phase is dedicated to general injection products in the form of liquid and powder vials, which will be put into operation in 2021 and have the following specifications:
| Product volume (ml) | Annual production (million units) | product type | production line | phase |
| 15-100 | 15 | Liquid and powder | General Vial | 3 |
Phase 4:
This phase is dedicated to injectable anti-cancer products in liquid vials, which are under construction for specific diseases under the title of research and development site, which will be finalized in 2022 and has the following specifications:
| Product volume (ml) | Annual production (million units) | product type | production line | phase |
| 5-50 | 5 | Liquid | Anti-cancer vial | 4 |
It is important to note that all four sites are designed according to FDA guidelines.
In this complex, 300 people will be employed during the full operation, including specialists, experts and professional and trained workers.